Information:
Fel:
ID
18407
Beskrivning
A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00087711
Länk
https://clinicaltrials.gov/show/NCT00087711
Nyckelord
Versioner (1)
- 2016-11-03 2016-11-03 -
Uppladdad den
3 november 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non Small Cell Lung Carcinoma NCT00087711
Eligibility Non Small Cell Lung Carcinoma NCT00087711
- StudyEvent: Eligibility
Similar models
Eligibility Non Small Cell Lung Carcinoma NCT00087711
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Non-Small Cell Lung Carcinoma | TNM clinical staging | Non-Small Cell Lung Carcinoma Amenable curative treatment
Item
diagnosis of nsclc stage iiib not amenable to curative treatment or stage iv.
boolean
C0007131 (UMLS CUI [1])
C3258246 (UMLS CUI [2])
C0007131 (UMLS CUI [3,1])
C3900053 (UMLS CUI [3,2])
C1273390 (UMLS CUI [3,3])
C3258246 (UMLS CUI [2])
C0007131 (UMLS CUI [3,1])
C3900053 (UMLS CUI [3,2])
C1273390 (UMLS CUI [3,3])
Prior Chemotherapy Malignant neoplasm of lung
Item
no prior chemotherapy for lung cancer.
boolean
C1514457 (UMLS CUI [1,1])
C0242379 (UMLS CUI [1,2])
C0242379 (UMLS CUI [1,2])
Measurable Lesion Linear Quantity
Item
patients must have at least one uni-dimensionally measurable lesion.
boolean
C1513041 (UMLS CUI [1,1])
C0205132 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0205132 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
prior radiation therapy Bone Marrow Percentage | Therapeutic radiology procedure Whole-Pelvis | Therapeutic radiology procedure Completed
Item
prior radiation therapy to less than 25% of bone marrow, whole pelvis not allowed. radiation must be completed at least 4 weeks prior to study enrollment.
boolean
C0279134 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C3827467 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C3827467 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
Drugs, Non-Prescription
Item
treatment with any drug within the last 30 days that has not received regulatory approval.
boolean
C0013231 (UMLS CUI [1])
Heart condition Serious
Item
serious cardiac condition.
boolean
C3842523 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
Disease Serious In addition to Non-Small Cell Lung Carcinoma | Compliance behavior Limited
Item
serious medical disorder in addition to nsclc that would make it difficult for the patient to complete the study.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332287 (UMLS CUI [1,3])
C0007131 (UMLS CUI [1,4])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])
C0332287 (UMLS CUI [1,3])
C0007131 (UMLS CUI [1,4])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
Folic Acid Intake Unwilling | Vitamin B12 supplement Intake Unwilling
Item
inability or unwillingness to take folic acid or vitamin b12 supplementation.
boolean
C0016410 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C3661610 (UMLS CUI [2,1])
C1512806 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
C1512806 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C3661610 (UMLS CUI [2,1])
C1512806 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Body fluid retention | Drainage Unsuccessful
Item
presence of fluid retention that cannot be controlled by drainage.
boolean
C0268000 (UMLS CUI [1])
C0013103 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
C0013103 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])